Healthcare · Drug Manufacturers Specialty Generic · NYSE
| Market cap | $2.60B |
|---|---|
| Trailing P/E | 13.0 |
| FCF yield | 9.2% |
| Revenue growth (YoY) | -4.3% |
| EPS growth (YoY) | -7.7% |
| FCF/share growth (YoY) | +4.1% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty Generic |
Prestige Consumer Healthcare Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Thomas R Tillis | Senate | Sell | $1,001 - $15,000 | — |